NCT03190278
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03190278
Title Study Evaluating Safety and Efficacy of UCART123 in Patients With Acute Myeloid Leukemia
Acronym AMELI-01
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectis S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 United States Details
Northwestern University Chicago Illinois 60201 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Weill Medical College of Cornell University New York New York 10021 United States Details
University of Pennsylvania - Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field